X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (91) 91
neurosciences (75) 75
humans (69) 69
index medicus (68) 68
alzheimer's disease (67) 67
mice (60) 60
female (43) 43
neurology (42) 42
male (40) 40
disease models, animal (38) 38
brain (33) 33
mice, transgenic (33) 33
a-beta (32) 32
brain - metabolism (31) 31
mice, inbred c57bl (28) 28
alzheimers-disease (27) 27
mild cognitive impairment (27) 27
alzheimer disease - metabolism (25) 25
alzheimer disease - pathology (23) 23
docosahexaenoic acid (23) 23
blood-brain barrier (21) 21
clinical neurology (21) 21
human necessities (21) 21
hygiene (21) 21
medical or veterinary science (21) 21
parkinson's disease (21) 21
preparations for medical, dental, or toilet purposes (21) 21
tau proteins - metabolism (21) 21
amyloid beta-peptides - metabolism (20) 20
specific therapeutic activity of chemical compounds ormedicinal preparations (20) 20
analysis (19) 19
pathology (19) 19
biochemistry & molecular biology (18) 18
aged (17) 17
brain - drug effects (17) 17
alzheimer disease - genetics (16) 16
basal ganglia (15) 15
dementia (15) 15
dyskinesia (15) 15
neurofibrillary tangles (15) 15
rodents (15) 15
brain - pathology (14) 14
mptp (14) 14
neurodegenerative diseases (14) 14
parkinsons-disease (14) 14
research (14) 14
aged, 80 and over (13) 13
dopamine (13) 13
genetic engineering (13) 13
mouse model (13) 13
proteins (13) 13
autoradiography (12) 12
macaca fascicularis (12) 12
omega-3 fatty acids (12) 12
peptide fragments - metabolism (12) 12
tau (12) 12
alzheimer’s disease (11) 11
amyloid-beta (11) 11
enzyme-linked immunosorbent assay (11) 11
l-dopa (11) 11
levodopa - adverse effects (11) 11
memory (11) 11
pharmacology & pharmacy (11) 11
phosphorylation (11) 11
polyunsaturated fatty-acids (11) 11
tau proteins - genetics (11) 11
transgenic mice (11) 11
amyloid beta-protein precursor - genetics (10) 10
endocrinology & metabolism (10) 10
fatty acids (10) 10
geriatrics & gerontology (10) 10
transgenic mouse model (10) 10
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (9) 9
3xtg-ad (9) 9
alzheimers disease (9) 9
analysis of variance (9) 9
blood–brain barrier (9) 9
cell biology (9) 9
dopamine - metabolism (9) 9
dyskinesia, drug-induced - metabolism (9) 9
foods or foodstuffs (9) 9
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (9) 9
indexing scheme relating to foods, foodstuffs or non-alcoholicbeverages (9) 9
lipids (9) 9
neurodegeneration (9) 9
neuroprotection (9) 9
oxidative stress (9) 9
parkinson (9) 9
parkinson disease - metabolism (9) 9
preservation of foods or foodstuffs, in general (9) 9
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (9) 9
their treatment, not covered by other classes (9) 9
alzheimer disease (8) 8
amyloid precursor protein (8) 8
blood-brain barrier - metabolism (8) 8
cognitive ability (8) 8
docosahexaenoic acids - metabolism (8) 8
expression (8) 8
immunoglobulins (8) 8
immunology (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Neurodegeneration, ISSN 1750-1326, 2011, Volume 6, Issue 1, pp. 70 - 70
APP expression misregulation can cause genetic Alzheimer's disease (AD). Recent evidences support the hypothesis that polymorphisms located in microRNA (miRNA)... 
microRNA, single nucleotide polymorphism | miR-147, miR-20a | Alzheimer's disease | Amyloid precursor protein | MicroRNA | Amyloid beta-protein | Physiological aspects | Genetic aspects | Research | Single nucleotide polymorphisms | Health aspects | Risk factors | Neurosciences | Regulation | Kinases | Bioinformatics | Dementia | Validation studies
Journal Article
Journal Article
Neuron, ISSN 0896-6273, 2004, Volume 43, Issue 5, pp. 633 - 645
Learning and memory depend on dendritic spine actin assembly and docosahexaenoic acid (DHA), an essential n-3 (omega-3) polyunsaturated fatty acid (PFA). High... 
LIPID-PEROXIDATION | POSTSYNAPTIC DENSITY-95 | PHOSPHATIDYLINOSITOL 3-KINASE | NICOTINIC ACETYLCHOLINE-RECEPTOR | A-BETA | AMYLOID-PRECURSOR-PROTEIN | POLYUNSATURATED FATTY-ACIDS | COGNITIVE IMPAIRMENT | LONG-TERM POTENTIATION | NEUROSCIENCES | TRANSGENIC MICE | Dendrites - pathology | Apoptosis - drug effects | Humans | Actins - metabolism | Apoptosis - genetics | Male | Phosphatidylinositol 3-Kinases - metabolism | Synapses - pathology | Carrier Proteins - drug effects | Protein Subunits - metabolism | Alzheimer Disease - pathology | Brain - metabolism | Dietary Fats, Unsaturated - pharmacology | Dietary Fats, Unsaturated - metabolism | Synapses - metabolism | Alzheimer Disease - prevention & control | Female | Phosphorylation - drug effects | Disease Models, Animal | Docosahexaenoic Acids - therapeutic use | Dendrites - drug effects | Dendrites - metabolism | Synapses - drug effects | Oxidative Stress - genetics | Mice, Transgenic | Neuropeptides - metabolism | Microscopy, Electron | Food, Formulated | Down-Regulation - genetics | Brain - drug effects | Nerve Tissue Proteins - metabolism | Docosahexaenoic Acids - pharmacology | Animals | Carrier Proteins - metabolism | Alzheimer Disease - metabolism | Brain - pathology | Mice | Oxidative Stress - drug effects | bcl-Associated Death Protein | Docosahexaenoic Acids - metabolism | Proteins | Pathology | Medical research | Scholarships & fellowships | Brain research | Neuropathology | Memory | Mortality | Swimming | Fatty acids | Mental retardation
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 2, p. e17397
Defects in neuronal activity of the entorhinal cortex (EC) are suspected to underlie the symptoms of Alzheimer's disease (AD). Whereas neuroprotective effects... 
BETA-AMYLOID ACCUMULATION | SYNAPTIC NOISE | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | DIETARY DOCOSAHEXAENOIC ACID | MOUSE MODEL | POLYUNSATURATED FATTY-ACIDS | TRIPLE-TRANSGENIC MODEL | RECOGNITION MEMORY | MEMBRANE CAPACITANCE | PREFRONTAL CORTEX | Arachidonic Acid - metabolism | Entorhinal Cortex - metabolism | Alzheimer Disease - pathology | Cognition Disorders - prevention & control | Osmolar Concentration | Alzheimer Disease - prevention & control | Cytoprotection - drug effects | Neurons - physiology | Arachidonic Acid - analysis | Neurons - metabolism | Drug Evaluation, Preclinical | Neurons - drug effects | Alzheimer Disease - physiopathology | Cognition Disorders - physiopathology | Neurons - chemistry | Cognition Disorders - pathology | Mice, Transgenic | Cognition Disorders - genetics | Entorhinal Cortex - drug effects | Cognition - drug effects | Down-Regulation - drug effects | Entorhinal Cortex - chemistry | Docosahexaenoic Acids - pharmacology | Animals | Brain Chemistry | Mice | Alzheimer Disease - genetics | Entorhinal Cortex - physiology | Prevention | Advertising executives | Unsaturated fatty acids | Neurons | Physiological aspects | Cognition | Alzheimer's disease | Omega-3 fatty acids | Neuroprotection | Brain | Animal models | Memory | Cognitive ability | Neurobiology | Lipids | Docosahexaenoic acid | Proteins | Rodents | Physiology | Synaptophysin | Neurodegenerative diseases | Firing rate | Pattern recognition | Object recognition | Fatty acids | Cortex (entorhinal) | Morphology | Glutamatergic transmission | Alzheimers disease | Surface area | Synapses
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 4/2016, Volume 131, Issue 4, pp. 481 - 504
Years of research have highlighted the importance of the immune system in Alzheimer’s disease (AD), a system that, if manipulated during strategic time... 
Pathology | Neurosciences | Immunization | Immunoglobulins | Medicine & Public Health | Lymphocytes | Clinical trials | IVIg | Blood–brain barrier
Journal Article
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 10/2011, Volume 8, Issue 1, pp. 137 - 137
Background: Mounting evidence supports a significant role of inflammation in Parkinson's disease (PD) pathophysiology, with several inflammatory pathways being... 
Inflammation | Dopamine | Parkinson's disease | MPTP | Myd88 | NADPH OXIDASE | MICROGLIAL ACTIVATION | Parkinson?'?s disease | NITRIC-OXIDE SYNTHASE | TOLL-LIKE RECEPTOR | IMMUNOLOGY | MyD88 | SUBSTANTIA-NIGRA | NEUROSCIENCES | FACTOR-ALPHA | TUMOR-NECROSIS-FACTOR | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | MOUSE MODEL | PARKINSONS-DISEASE | Substantia Nigra - pathology | Dopaminergic Neurons - pathology | Humans | Astrocytes - pathology | Substantia Nigra - metabolism | Glial Fibrillary Acidic Protein - metabolism | Corpus Striatum - cytology | Corpus Striatum - metabolism | Substantia Nigra - cytology | Dopaminergic Neurons - metabolism | Dopaminergic Neurons - drug effects | MPTP Poisoning - pathology | Toll-Like Receptors - metabolism | Corpus Striatum - pathology | Dopamine - metabolism | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology | Astrocytes - drug effects | 3,4-Dihydroxyphenylacetic Acid - metabolism | Mice, Inbred C57BL | Myeloid Differentiation Factor 88 - genetics | Mice, Knockout | Neurotoxins - pharmacology | Autoradiography | Animals | MPTP Poisoning - metabolism | Toll-Like Receptors - genetics | Signal Transduction - physiology | Mice | Myeloid Differentiation Factor 88 - metabolism | Astrocytes - metabolism | Physiological aspects | Brain | Genetic aspects | Research | Dopaminergic mechanisms | Studies | Proteins | Medical research | Kinases | Immune system | Apoptosis
Journal Article
Trends in Food Science & Technology, ISSN 0924-2244, 11/2017, Volume 69, p. 203
Journal Article
Journal of Neuropathology and Experimental Neurology, ISSN 0022-3069, 01/2009, Volume 68, Issue 1, pp. 48 - 58
Journal Article
Journal Article